Fluvastatin Sodium Patent Expiration
Fluvastatin Sodium was first introduced by Novartis Pharmaceuticals Corp
Fluvastatin Sodium Patents
Given below is the list of patents protecting Fluvastatin Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lescol Xl |
US6242003 (Pediatric) | Organic compounds |
Oct 13, 2020
(Expired) | Sandoz |
| Lescol Xl | US6242003 | Organic compounds |
Apr 13, 2020
(Expired) | Sandoz |
Fluvastatin Sodium's Family Patents
Explore Our Curated Drug Screens
Fluvastatin Sodium Generic API Manufacturers
Several generic applications have been filed for Fluvastatin Sodium. The first generic version for Fluvastatin Sodium was by Mylan Pharmaceuticals Inc. and was approved on Apr 11, 2012. And the latest generic version is by Beijing Sciecure Pharmaceutical Co Ltd and was approved on Apr 26, 2021.
Given below is the list of companies who have filed for Fluvastatin Sodium generic, along with the locations of their manufacturing plants worldwide.
1. BEIJING
Beijing Sciecure Pharmaceutical Co Ltd has filed for 1 generic for Fluvastatin Sodium. Given below are the details of the strengths of this generic introduced by Beijing.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 26, 2021 |
Manufacturing Plant Locations New
Beijing's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Beijing as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc. has filed for 2 different strengths of generic version for Fluvastatin Sodium. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE | capsule | Prescription | ORAL | AB | Apr 11, 2012 |
| EQ 40MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | Apr 11, 2012 |
3. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Fluvastatin Sodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 11, 2015 |
4. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Fluvastatin Sodium. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
| EQ 20MG BASE | capsule | Prescription | ORAL | AB | Jun 12, 2012 |
5. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Fluvastatin Sodium. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet, extended release | Prescription | ORAL | AB | Jan 27, 2016 |